Companies
Employees11-50
Funding$8M
Healthcare AIFoundation Model ProviderB2B SaaSSeed$1M-$10M
About
Cassidy Bio is an AI-first biotechnology company that builds a programmable platform for gene editing design. Using genomic foundation models, it replaces traditional trial-and-error design with predictive workflows for guides, enzymes, and delivery contexts. The company targets developers of advanced genetic medicines and therapies.
Active Roles
0No active roles right now.
Get notified when they postKey Investors
Ahren Innovation Capital, Lool Ventures, 10D VC, AstraZeneca, Merck KGaA